Untitled Document

[00:00:31] 200% 300% 500% 700% a little bit more [00:00:36] than that. So today I'm thrilled to [00:00:38] announce that the two world's largest [00:00:41] pharmaceutical manufacturers Eli Liy and [00:00:45] Novo Nordis have agreed to offer their [00:00:48] most popular GLP1 weight loss drug. I [00:00:53] call it the fat drug. Remember [00:00:56] at drastic discounts very effective [00:01:00] drugs and so far I've never heard [00:01:02] anything bad about them. Why only you're [00:01:03] good about it? It's pretty. Is there [00:01:05] anything bad about him, Bobby? I don't [00:01:07] know. I haven't heard anything. [00:01:10] Someday maybe it'll come out, which will [00:01:13] notify [clears throat] you immediately, [00:01:15] but so far I haven't heard that. [00:01:16] Including the drugs known as Zepound and [00:01:20] Wiggoi, [00:01:22] often called Ozepic. [00:01:25] This is a triumph for American patients [00:01:27] that will save lives and improve [00:01:30] the health of millions and millions of [00:01:32] Americans. Amazing thing. They are [00:01:34] amazing. I want to thank [00:01:38] Eli Liy CEO David Ricks, a friend of [00:01:40] mine. We've worked long and hard. He he [00:01:43] and I got this whole thing started in a [00:01:45] way. And Novo Ner CEO [00:01:48] Mike Dustar [00:01:51] for joining us today. great [00:01:53] [clears throat] [00:01:54] talented people. They make a lot of [00:01:57] money. I looked at the money, but [00:01:59] they're entitled to the money because [00:02:00] the companies are doing very well. Along [00:02:03] with Secretary Robert F. Kennedy Jr., [00:02:05] Secretary Howard Lutnik, [00:02:08] do you take any of this stuff, Howard? [00:02:10] >> Not yet. [00:02:11] >> Okay, good. CMS administrator Meaz, he [00:02:15] doesn't take it. Food and Drug [00:02:18] Administrator, [00:02:21] Commissioner Marty McCary, and Director [00:02:24] of Medicare Chris Plump. [00:02:27] And we have Steve. Where's Steve? Is she [00:02:30] here? Head of public relations for the [00:02:33] White House. [00:02:35] He's taking it. [00:02:39] The United States is just 4% of the [00:02:42] world's population and consumes only 13% [00:02:45] of all prescription drugs. Yet, [00:02:48] pharmaceutical companies make 75% of [00:02:51] their profits from their American [00:02:53] customer. I would say that's [00:02:56] not so good, right? That's not exactly [00:02:59] great. To address this chronic [00:03:01] unfairness, I signed an executive order [00:03:03] earlier this year, instructing my [00:03:06] administration to do everything in our [00:03:08] power to implement most favored nations [00:03:10] drug pricing, something that has uh been [00:03:14] helped greatly by tariffs because when [00:03:16] nations refuse to do it, we should have [00:03:19] put this in the case yesterday. I just [00:03:21] say, "Well, if you're not going to do [00:03:22] it, we're going to charge you a like [00:03:24] amount of tariffs." And they immediately [00:03:26] say, "We'll do it." [00:03:28] which means that Americans should pay no [00:03:30] more than the lowest price offered [00:03:32] anywhere in the world. So that you've [00:03:35] heard for years a disparity where you'll [00:03:38] pay $150 for a pill in New York and [00:03:40] you'll pay $10 for a pill in London. Now [00:03:43] you're going to pay $20 both because the [00:03:46] world is a little bit bigger than the [00:03:47] US. So it goes up that way. But you'll [00:03:49] pay $20 and $20. a tremendous advantage [00:03:53] to [00:03:55] our country after years of being abused [00:03:58] by the world system. Already fizer, [00:04:00] Astroenica and EMD, Serrano have agreed [00:04:04] to drastically lower their prices for [00:04:07] American patients. And today, Eli Lily [00:04:10] and Novo Nordisk are joining the [00:04:13] phenomenal list of the most exciting [00:04:16] announcements. I mean, nobody's ever had [00:04:18] announcements like and this has to do [00:04:20] with other pharmaceutical products also, [00:04:24] but we're covering this today because [00:04:26] it's such a big seller. I guess it's the [00:04:28] number one selling thing there is today. [00:04:31] These are two companies that behind the [00:04:33] groundbreaking weight loss drugs that [00:04:34] have helped millions of Americans [00:04:36] struggling with obesity live better, [00:04:39] longer lives, everything else. These are [00:04:41] the two companies that really broke [00:04:43] ground. Until now, neither of these two [00:04:45] popular drugs have been covered by [00:04:47] Medicare for weight loss, and they've [00:04:50] only rarely been covered by Medicaid. [00:04:53] They've often cost consumers more than [00:04:56] $1,000 per month, and some a lot more [00:04:59] than that. Americans have been spending [00:05:02] as much as 520% more for Zepbound and [00:05:06] 1,400% [00:05:08] more for Wiggoi than patients in Europe. [00:05:11] Think of that. 1,400% more than a [00:05:14] patient year for the exact same box. [00:05:17] And that ends starting today. The other [00:05:20] countries are not happy with us. I don't [00:05:23] think they like me too much, Bobby, but [00:05:25] that's okay. Eli Lilly and Novo Nordisk [00:05:28] are committing to offer Zepbound and [00:05:30] Wiggoi at most favored nations rates for [00:05:33] American patients. This will slash the [00:05:36] cost of Wiggoi from $1,350 [00:05:41] a month to ultimately $250 a month. [00:05:45] $1,350 to $250. Did I do a good job? [00:05:50] They don't write about it. You know, [00:05:51] they like to not write these things. And [00:05:53] reduce you think anybody, you think [00:05:55] Biden could have done this? I don't [00:05:56] think so. And reduce the monthly cost of [00:05:59] Zepbound from $1,080 [00:06:02] to $346. [00:06:05] In addition, they're both committing [00:06:07] that future GLP-1 weight loss drugs [00:06:10] taken orally, which are currently under [00:06:13] development, will be sold at no more [00:06:15] than $149 per month. It's a massive, [00:06:20] think of that. You go from $1,300 to [00:06:22] $149 a month. We anticipate these new [00:06:26] versions will be coming out in a very [00:06:29] short period of time. All of these drugs [00:06:31] will be available directly to the [00:06:33] consumer [00:06:36] [music] [00:06:40] name Trump. It better be good. Trump [00:06:44] rx.gov. And I I think it's turning out [00:06:46] to be pretty amazing, right? [00:06:49] Just as significantly, Medicare and [00:06:51] Medicaid will finally cover the cost of [00:06:53] these weight loss drugs for millions of [00:06:56] patients suffering from obesity. Co-pays [00:06:59] for Medicare patients will be as low as [00:07:02] $50. [00:07:04] This is tremendous savings. I mean, now [00:07:07] you're talking about from $1,350 [00:07:10] to $50. [00:07:13] This is tremendous news for the American [00:07:15] seniors. And you all remember what I had [00:07:18] 1/8 of 1% for the year. I cut it 1/8 and [00:07:21] I was so thrilled. But now we're cutting [00:07:23] it a,000% 1,200%. Nobody's ever seen [00:07:26] anything like this. Nobody else could [00:07:29] have done it. But I say that modestly. [00:07:32] In addition, you think it was easy [00:07:33] dealing with these people? It wasn't. [00:07:36] You think it was easy saying your drug, [00:07:39] Mr. Eli Liy, that was selling for 1300 [00:07:42] is going to be sold for 250. [00:07:45] You know, the amazing thing, the stocks [00:07:46] all went up. I mean, these guys are [00:07:49] they're fantastic because it's going to [00:07:52] equalize the world. world's a bigger [00:07:54] place and it's going to equalize. I was [00:07:58] a little surprised to see that, but I'm [00:07:59] happy about it. In addition, Eli Liy and [00:08:01] Novo Nordisk have agreed to provide all [00:08:04] of their other medications to Medicaid [00:08:07] at most favored nations prices. Most [00:08:10] favored nations, meaning that you will [00:08:12] pay the lowest price anywhere in the [00:08:14] world. That's what you're going to pay. [00:08:16] Whereas before they paid low prices and [00:08:18] we paid you know thousands of percentile [00:08:22] ahead more and to sell these drugs to [00:08:26] all consumers at deeply discounted [00:08:28] prices via trumpx.com. [00:08:31] When is Trump rx.com opening? [00:08:34] >> It's the site is open. The it will [00:08:36] launch in terms of giving people prices [00:08:38] before the end of the year. [00:08:39] >> Okay. Got to make sure it's successful. [00:08:40] It's got my name on it. I don't want to [00:08:43] be like so many others. I don't want to [00:08:46] be like the train they're building in [00:08:47] California, [00:08:49] okay? Which has about 15,000% [00:08:52] cost overrun. Or the Obama the beautiful [00:08:56] Obama building that he's building in [00:08:58] Chicago for the museum which is now [00:09:01] shuted up and dead. They got it up and [00:09:05] they couldn't finish. It's about would [00:09:08] you say five years behind schedule [00:09:10] >> and about 2,000% over budget. Then he [00:09:13] tells us how to run Medicaid. [00:09:16] Many of the most widely used drugs will [00:09:18] be available for 60% [00:09:20] off or even more than that. In addition, [00:09:24] all new medications introduced by Eli [00:09:27] Liy and Novo Nordisk to the American [00:09:31] market will be sold at the heavily [00:09:33] reduced most favored nations price most [00:09:36] favored nations price estimates [00:09:38] because they have been thousands of [00:09:41] percent lower than what we were selling [00:09:44] in many cases. Furthermore, Eli Lily is [00:09:47] investing 27 billion dollar. [00:09:50] That's all. and Novo Nordisk will invest [00:09:53] 10 billion dollars. That's all. That's [00:09:55] peanuts [00:09:57] in the United States to reshore [00:10:00] do a big domestic manufacturing job in [00:10:04] the facilities. They're going to spend [00:10:06] so Eli Li spent 27 billion. Novo is [00:10:09] spending 10 billion in the United [00:10:12] States. So they're building new plant [00:10:14] and equipment. Uh that's part of [00:10:18] what will be 20 or 21 trillion dollars [00:10:21] this year. There's never been anything [00:10:22] like it. I know nobody talks about it, [00:10:24] but there's never been anything like I [00:10:26] would say you would say that there's [00:10:28] never been anything like this ever in [00:10:30] whether it's China or Europe or you [00:10:34] could take all of Europe. There's never [00:10:35] been anything like this. So we're [00:10:37] already past 17 trillion. We're going to [00:10:39] be I think by the time the year closes [00:10:41] out, we'll have investments of over $21 [00:10:44] trillion based on the way we're going. [00:10:46] And and by the way, tariffs are very [00:10:48] important. Without tariffs, uh perhaps [00:10:51] it could be a little bit different. To [00:10:53] put it mildly, tariffs are so important. [00:10:56] The decision in the Supreme Court would [00:10:59] be devastating to our country if we got [00:11:01] a negative devastating if we got a [00:11:04] negative decision. [00:11:06] But this is a great day for American [00:11:09] health and healthcare and for all of [00:11:11] American patients. These are things that [00:11:13] are miracles to have this happen. And [00:11:15] there, you know, we're bringing all our [00:11:17] medicines again because of terrorists. [00:11:19] We're bringing all our medicines. If you [00:11:21] remember where during co we made almost [00:11:25] no medicine here. We had to go to China. [00:11:27] We had to go to Ireland. We had to go to [00:11:29] other places, UK to get our med. We [00:11:32] didn't make it here. Now we're making [00:11:33] it. will soon be making it all here [00:11:35] again because of tariffs and my [00:11:38] election, but because of tariffs, much [00:11:40] more. For years, politicians have talked [00:11:43] about making healthc care affordable, [00:11:45] but my administration is actually doing [00:11:47] it. Americans deserve the best [00:11:50] healthcare in the world, and we're now [00:11:52] getting the best healthcare at the [00:11:53] lowest price. So, I'd like to ask uh [00:11:56] somebody who's doing a fantastic job, [00:11:58] Secretary Kennedy, to say a few words, [00:12:01] followed by Dr. [00:12:03] Dr. Klopp and then Eli Liy CEO David [00:12:07] Ricks and Novo Notes [00:12:11] CEO Mike Dustar. [00:12:14] These are incredible stars in that [00:12:16] business. I like Destar is a big star. [00:12:20] Uh, and I can tell you that David Ricks [00:12:23] is one of the hottest people in the [00:12:25] world in business, but uh, the business [00:12:28] that he's in is pharmaceutical and the [00:12:30] job he's done with Eli Liy is [00:12:32] incredible. Both of these gentlemen, [00:12:34] they're they really are stars in the [00:12:36] truest sense and it's an honor to have [00:12:38] you in the White House and go to it, [00:12:40] Bobby. [00:12:43] >> Thank you, Mr. President. I want to [00:12:45] start by thanking you, Mr. president are [00:12:48] declaring war on chronic disease in this [00:12:51] country. This is something no American [00:12:53] president has ever done. If we want to [00:12:56] solve the chronic disease crisis, we [00:12:58] have to tackle it. Obesity. [00:13:01] Obesity is the number one driver of [00:13:05] chronic disease. [00:13:07] 50% of our uh adult population are obese [00:13:12] or overweight. It drives about 50% of [00:13:16] health care costs in this country. [00:13:18] Diabetes, cardiac diseases. We are going [00:13:21] to see a decline because of this [00:13:23] historic agreement. We're going to see a [00:13:26] decline in cost but also more [00:13:28] importantly [00:13:30] in the afflictions themselves. There are [00:13:34] uh this is a President Trump is the [00:13:39] friend of the forgotten American. [00:13:42] Obesity is a disease of poverty [00:13:45] overwhelmingly and this drug these drugs [00:13:50] have only been available for people who [00:13:53] have wealth. At one point, the majority [00:13:56] of prescriptions, the highest [00:13:58] concentration of prescriptions in this [00:14:00] country was the upper west side of [00:14:02] Manhattan. And what about the people who [00:14:05] live in rural areas, who live in food [00:14:07] deserts? What about the people in urban [00:14:10] areas who live in food deserts and are [00:14:12] suffering from obesity and are locked [00:14:15] into that system where they can only get [00:14:18] ultrarocessed foods which are [00:14:20] aggravating the problem. This will be a [00:14:22] lifesaver to them. It's not a panacea. [00:14:26] It's not a silver bullet. President [00:14:28] Trump has also instructed us to [00:14:31] address and end the root causes of [00:14:34] chronic disease. And we're doing that. [00:14:36] We're about to release dietary [00:14:38] guidelines that are going to change the [00:14:41] food culture in this country. They're [00:14:42] going to change the kind of food the [00:14:44] military gets. They're going to change [00:14:46] the kind of food that our children get. [00:14:48] We're releasing those in December. The [00:14:51] presidential council for physical [00:14:52] fitness is going to get more Americans [00:14:56] into particularly our children into [00:14:59] physical activity so that we can attack [00:15:01] the root causes of this. But in the [00:15:03] meantime, there's nothing more important [00:15:05] than we can do than lower this price. As [00:15:08] I said, it is the number one cause of [00:15:11] all drugs. This is the biggest drug in [00:15:14] our country. That's why this is the most [00:15:16] important of all the MFN announcements [00:15:19] we've made. This is going to have the [00:15:21] biggest impact on the American people. [00:15:24] All Americans, even those who are not on [00:15:26] Medicaid and Medicare, are going to be [00:15:28] able to get the same price for their [00:15:30] drugs for their GLP drugs. This happened [00:15:36] because of the vision of David Ricks, of [00:15:39] Mike Dustar and the other people and the [00:15:42] people on our team who who figured out a [00:15:46] way to align the interests of the [00:15:48] shareholders of their company with the [00:15:51] health of the American public and it is [00:15:54] a momentous accomplishment. It took [00:15:56] months and months of negotiations [00:15:59] and I had a wonderful conversation with [00:16:02] Mike Dustar um [00:16:05] about his experience and he thanked me [00:16:10] for the caliber of people who were on [00:16:14] our side of the negotiating team. Chris [00:16:15] Clump who walked away from a [00:16:18] billion-dollar business in order to join [00:16:20] this administration in La Hernandez, [00:16:24] David Brooks, and of course Dr. Oz and [00:16:27] Marty McCary who made this happen. They [00:16:30] saw that this could be a win-win [00:16:32] situation, [00:16:33] that this was not a zero sum game. The [00:16:36] Biden administration tried to solve this [00:16:38] problem unsuccessfully, I might add, by [00:16:42] throwing $40 billion at it. and they [00:16:45] were able to achieve an agreement that [00:16:47] will actually create savings for the [00:16:50] American public. So, we're making all of [00:16:53] this available at a savings and that's [00:16:56] because the price of diabetes [00:16:58] prescriptions is also going to drop and [00:17:01] the savings that we get from that are [00:17:03] now going to be make it available to [00:17:05] people who do not have diabetes. People [00:17:08] who have a BMI of 27 and above or [00:17:11] pre-diabetic or have heart disease risk, [00:17:14] they will be able to get it. But [00:17:15] everybody will be able to get this drug. [00:17:18] And it is going to it's going to change. [00:17:21] We will lose the American public because [00:17:23] of this agreement will lose 125 million [00:17:27] pounds by this time next year. It is [00:17:30] going to have dramatic effects on human [00:17:32] health in this country. And I want to [00:17:35] thank President Trump for his [00:17:37] leadership. He said that I'd gotten a [00:17:39] lot done as HHS secretary, but almost [00:17:42] none of that is due to my ability. It's [00:17:46] because I'm surrounded by people who are [00:17:48] smarter than me or more able than me. [00:17:51] And those people came into the [00:17:54] administration because they were [00:17:55] inspired by President Trump. People like [00:17:58] Chris are here because they see this. [00:18:01] >> Do you think they are smarter than you [00:18:02] and [00:18:04] Believe me, they're lots more than I am. [00:18:06] >> Why did you take that job? [laughter] [00:18:12] >> It doesn't really mean that he's being [00:18:13] modest. I promise you, but [00:18:16] >> it is true. Unfortunately, [00:18:18] >> it's a beautiful thing. [00:18:20] >> But I want to thank you, Mr. President, [00:18:22] because you've been able you've made me [00:18:24] a success here by allowing me to attract [00:18:26] these extraordinary people. And I want [00:18:29] to again thank David Ricks who we've [00:18:32] been talking we've been in this whole [00:18:34] office again and again and you keep [00:18:36] saying is the smartest guy in industry [00:18:38] that he could talk a dog off a meat [00:18:40] truck. Um but but they came to the table [00:18:45] and Mike Newart told me he said [00:18:47] >> I did convince people for 20 years that [00:18:51] it was okay for Europe to pay $10 and [00:18:54] for America to pay $140. That's why they [00:18:56] make 4550 million a year. He did finally [00:19:00] I said I had it right. [00:19:02] >> You did. [00:19:02] >> He did. But anybody could do that, [00:19:05] they're entitled. But now it's down to [00:19:08] what it should be. [00:19:10] >> And Mike Dart told me what a pleasure it [00:19:13] was to negotiate with people who were [00:19:15] smart, who had common sense, who were [00:19:19] able to put themselves in his position [00:19:22] and hammer out this deal that is good [00:19:24] for everybody. [00:19:26] and it's great for the American public. [00:19:27] I want to close again by just saying [00:19:30] that this is a tool and toolkit. It is [00:19:33] not a silver bullet. It is an arrow in [00:19:37] our quiver. It will allow a lot of [00:19:39] people who are locked into high-risisk [00:19:41] obesity to finally lose weight to reset [00:19:45] and then start doing the kind of things [00:19:47] that will address the root causes of [00:19:50] obesity. So, I want to thank these [00:19:53] extraordinary CEOs [00:19:56] for that, for sticking with us on this, [00:19:58] for allowing us to make this happen. [00:20:01] Mike Dustar said to me, he said, "We've [00:20:04] known we've had to do this for many [00:20:06] years. We just haven't been able to get [00:20:09] over the edge." And that this President [00:20:11] Trump's order, his executive order, was [00:20:14] a catalyst to do something that we [00:20:17] always knew needed to be done. So again, [00:20:19] thank you for your vision, for your [00:20:21] commitment, and thank you to all the [00:20:23] CEOs and all of my team are making this [00:20:26] historic agreement happen. [00:20:28] >> Bobby, you haven't changed your view on [00:20:29] Tylenol for women. [00:20:33] >> As I said, [00:20:34] >> there's some false reports out about [00:20:36] Tylenol that uh Bobby changed his view. [00:20:39] I don't think he's changing. [00:20:40] >> I'm not going to change until the [00:20:41] science changes. And the science does [00:20:43] not look like it's changing. It's [00:20:45] getting stronger and stronger every day. [00:20:47] What we recommend is that mothers, [00:20:50] pregnant mothers talk to their [00:20:52] physicians, that that uh mothers of [00:20:55] small kids talk to their physicians. And [00:20:57] we've advised the physicians [00:21:00] to reduce the thresholds and to reduce [00:21:02] the amount of Tylenol that they give to [00:21:05] children as much as possible and only [00:21:07] use it when it's absolutely critical. [00:21:10] >> Thank you. [00:21:13] >> So, uh we're going to go through some of [00:21:15] the deal points. Uh but it does [00:21:19] make itself clear that the real stake [00:21:22] here is the forgotten man. President [00:21:24] Trump, I believe you won the election [00:21:26] because you remember the forgotten man. [00:21:27] You speak to them. They hear you. They [00:21:29] listen to you. And he connects well [00:21:31] because he actually does things that [00:21:32] materially change their lives. Secretary [00:21:35] Kennedy spoke passionately, as he always [00:21:37] does, about the problems with obesity. [00:21:40] And just to put some very fine point [00:21:41] numbers on this, obesity itself is [00:21:44] responsible for half of all chronic [00:21:45] disease and definitely generates more [00:21:47] than a quarter of all the money we spend [00:21:49] out of CMS, the $1.75 trillion that we [00:21:52] spend annually. We need to address this [00:21:55] tempest of dramatically increasing [00:21:58] prices for health care. And you're not [00:22:00] going to do it just by throwing money at [00:22:01] the problem. You have to actually [00:22:03] literally deal with the causes of the [00:22:05] increase in price. And pharmaceutical [00:22:07] prices are a part of that. They've been [00:22:08] a part of it for a long time, but this [00:22:10] president insisted that we address it. [00:22:12] In fact, the first time I heard this [00:22:14] directly from you, sir, was in January [00:22:15] at Mara Lago, where he took Secretary [00:22:16] Kennedy, myself, uh, Mr. Ricks, who hear [00:22:19] from in a second to dinner and demanded [00:22:22] explanations for most favored nation [00:22:24] pricing and what what's wrong with it. [00:22:26] And there was not a good reason against [00:22:27] it. Now, MA is critical. America will [00:22:32] have to get fit in order to rightsize [00:22:34] the health care system. And MA has the [00:22:35] answers. It has obesity management [00:22:37] through diet and exercise and sleep and [00:22:39] dealing with issues related to that. And [00:22:41] I want to say it as clear as I can. [00:22:43] Obesity is not an absence of GLP-1 [00:22:46] drugs. We're all clear on that. But as [00:22:49] Secretary Kennedy said, it is an arrow [00:22:50] in our quiver that we must use and [00:22:52] should use. The MA means making it [00:22:55] easier for the right things to happen. [00:22:57] Easier for you to be healthy. If you're [00:22:59] sitting at home and watching, that's [00:23:00] what Maha means to me. Reducing cost of [00:23:03] the number one most expensive medicine [00:23:04] category in our country for Americans [00:23:07] does just that. It is as maha as it [00:23:09] gets. Today's the fourth MFN. President [00:23:12] Trump highlighted the first three. You [00:23:14] know, leading US company, leading [00:23:16] European company. We've dropped [00:23:18] infertility drugs who will make lots of [00:23:19] Trump babies, I'm hoping by the [00:23:21] midterms. But it's really about [00:23:22] fairness. Fundamentally, it's fairness [00:23:24] and pricing to Americans who have been [00:23:26] getting ripped off, paying three times [00:23:28] more than their European counterparts [00:23:30] for the exact same product made in the [00:23:31] same factory, in the same bottle, in the [00:23:33] same packaging. We shouldn't be paying [00:23:34] three times more, and we are no longer [00:23:36] doing that. Fairness of the forgotten [00:23:38] man also means dealing with the reality [00:23:39] that they can afford a life-saving, [00:23:42] life-changing drug that 10% or more of [00:23:45] affluent Americans take, but folks [00:23:47] without means can't manage it. you, [00:23:50] President uh Secretary Kennedy mentioned [00:23:53] uh New York City. It actually the number [00:23:54] one zip code is the upper east side [00:23:56] which is where you have property and [00:23:57] folks who know ritzy areas buy important [00:24:00] real estate there because those real [00:24:02] estate properties are worth a lot there. [00:24:04] That should not be the number one zip [00:24:05] code in America for purchasing GLP-1 [00:24:08] drugs. It speaks to the fact that we [00:24:09] have an inherently innately unfair [00:24:11] system that penalizes folks who can use [00:24:13] these medications the most. folks in the [00:24:15] rust belt and what are you supposed to [00:24:17] do if you the right thing to do for your [00:24:19] health is right there but you can't [00:24:20] afford to get it. Folks need to be able [00:24:22] to utilize these life-saving medications [00:24:24] and being fair about its distribution is [00:24:26] essential. And we are democratizing [00:24:28] democratizing access to these [00:24:30] medications and dealing with a moral [00:24:32] imperative to make sure that all [00:24:34] Americans have access to avoiding all [00:24:36] the obesity related complications by [00:24:38] making sure they can afford if they do [00:24:40] things right not just maja appropriate [00:24:42] uh interventions but also medications [00:24:44] like this. In fact, we think these deals [00:24:47] and this part's very important. We [00:24:49] believe these deals within two years, [00:24:51] within two years, by the time the ink [00:24:53] dries on these contracts that were [00:24:55] signed earlier today, within two years, [00:24:57] based on our health improvements, we [00:24:58] will be budget neutral. These will these [00:25:00] drugs will not cost us money. The [00:25:02] American taxpayers will be getting their [00:25:03] money back. That's how important it is [00:25:05] for reducing for us to reduce the cost [00:25:07] of health care in this country, [00:25:08] especially when it's due to preventable [00:25:10] problems like obesity. In addition, we [00:25:13] have an update, Secretary Kennedy. We [00:25:15] thought it was 125 million pounds. Mr. [00:25:17] President, our estimate based on the [00:25:19] company numbers as well is Americans [00:25:21] will lose 135 billion pounds by the [00:25:24] midterms. But I don't measure it in [00:25:26] pounds. I measure it and save lives. [00:25:28] People can sleep again because they can [00:25:30] breathe as when they go to bed. Folks [00:25:31] who whose knees don't hurt, people who [00:25:32] don't have heart attacks, renal failure, [00:25:34] dementia, all the things we know are [00:25:35] associated with obesity, and much more. [00:25:37] This wouldn't have happened if we didn't [00:25:39] have the right tools uh and had the [00:25:41] ability with a team that has been spoken [00:25:43] of early. So, I want to call out Abe [00:25:44] Sutton. He leads he's in the back right [00:25:46] there. He leads the CMS innovation [00:25:48] center. It made the deal possible and is [00:25:50] and they're announcing today a new [00:25:51] model, a brand new model aimed at [00:25:53] getting to the vulnerable populations [00:25:55] amongst us these medications. The [00:25:57] forgotten man will be able to afford [00:25:58] these drugs now. Governors will be [00:26:00] thanking President Trump. They should be [00:26:02] calling directly, sir, because they're [00:26:03] going to be able to afford Medicaid next [00:26:06] year in ways unimaginable and they will [00:26:08] stop crowding out education and other [00:26:09] civil services. We cannot be a wealthy [00:26:12] nation without being a healthy nation. [00:26:14] That's why today's MFN deal is a [00:26:16] historic step forward for all America [00:26:19] who's and this is something that I don't [00:26:21] think is partisan. There is no way you [00:26:22] can argue against what just happened. [00:26:24] These numbers to my side here, Dex uh [00:26:27] administrator McCary who's been [00:26:28] instrumental in this process as well, [00:26:30] $1350 baseline. Uh Chris Clump will go [00:26:33] through the numbers, but just focus on [00:26:34] that 245 which is which he's going to [00:26:36] point you to. And Chris Clump has been [00:26:37] an unbelievable leader, an innovator [00:26:39] who's you've heard his name before, he's [00:26:41] spoken here before, but he is continuing [00:26:43] to change uh the face of of of CMS. And [00:26:46] I love the fact that with his [00:26:47] leadership, we're bringing a lot of [00:26:49] wonderful people in. In Hernandez, been [00:26:51] mentioned, John Brooks as well, and many [00:26:53] others including Beth Kelly um who runs [00:26:55] the legal issues around these issues [00:26:57] because these guys are barracudas, Mr. [00:26:58] President. They will take you down, [00:27:00] slice you in little bits. Uh and that [00:27:03] Howard's been there. It's no longer [00:27:05] happening. You've got sharp folks. We're [00:27:07] open for business. It's a generational [00:27:09] opportunity to serve and people are [00:27:10] showing up. God bless you. Let me [00:27:11] introduce now Chris Clump who is uh just [00:27:14] makes my life easier every day. I'm so [00:27:16] proud of them. [00:27:18] All great deals are rooted in [00:27:20] principles. We've talked about this [00:27:22] before and today we're announcing [00:27:24] another truly great deal. I love this [00:27:26] deal and it's rooted in the principle of [00:27:29] potential. This is about unlocking the [00:27:31] full potential of every American. the [00:27:33] grandmother, the grandfather, the [00:27:35] father, the son by unlocking access to [00:27:38] affordable life-saving medications that [00:27:40] make a meaningful difference in their [00:27:41] lives when they need them most. That's [00:27:44] what today delivers. It's a deal built [00:27:46] on principle for people, for the [00:27:49] American people, and backed by policy [00:27:51] that works. So the most important step [00:27:54] to getting healthy is believing that [00:27:56] your life has value. That God meant for [00:27:59] each of us to have purpose and joy and [00:28:02] to live fully. And to do that, we must [00:28:04] be good stewards of our body. And the [00:28:07] president has been fighting to provide [00:28:09] another tool to do just this and enable [00:28:12] this. And it's my pleasure to get to [00:28:13] outline the contours of the deal today. [00:28:16] So first and foremost, customary with [00:28:19] the three prior announcements, all of [00:28:21] the customary most favored nation terms [00:28:23] that you've grown familiar with apply to [00:28:25] these two deals. So this is actually [00:28:27] deals four and five. Uh uh full Medicaid [00:28:31] portfolios today at most favored nation [00:28:34] prices. Uh shared savings from existing [00:28:36] drug prices uh uh uh in Europe uh [00:28:40] deployed back to the United States. all [00:28:42] primary care drugs uh at US net prices [00:28:46] or most favored nation prices available [00:28:48] on Trump RX before the end of the year [00:28:50] and most importantly all future drug [00:28:54] launches across commercial Medicaid [00:28:56] Medicare and the cash markets at most [00:28:58] favored nation prices going forward. [00:29:01] Now GLP1s. So first under this agreement [00:29:04] starting doses of oral GLP1s will cost [00:29:07] just $149 a month for everyone. That's [00:29:11] roughly 1/8 the cost of the list price [00:29:13] today. For Medicare, manufacturers are [00:29:16] voluntarily reducing their prices for [00:29:18] GLP1s currently used for diabetes and [00:29:21] other covered indications to $245 [00:29:25] per month across all doses. The savings [00:29:29] generated from this change in prices [00:29:32] will be used to provide new coverage to [00:29:35] obesity [00:29:36] and and those who struggle with obesity [00:29:38] and also have high metabolic or [00:29:40] cardiovascular risk. Again, all for the [00:29:43] same $245 a month. That means Americans [00:29:48] struggling with diabetes and obesity [00:29:49] with heart disease or other chronic [00:29:51] conditions can access these [00:29:52] life-changing drugs more affordably. [00:29:55] Medicare patients, importantly, will [00:29:57] only pay $50 a month for a co-pay. This [00:30:00] is a massive reduction from what happens [00:30:03] today. For Medicaid, Novo and Lily have [00:30:05] agreed to extend the same new low [00:30:07] government pricing to all 50 state [00:30:10] Medicaid programs should they opt in. [00:30:12] And we encourage them to opt in. And [00:30:14] these will be available not just for [00:30:15] diabetes and current covered [00:30:16] indications, but also for obesity again. [00:30:20] And in case you're getting tired of me [00:30:22] saying it, at the same price of $245 a [00:30:25] month, all covered doses. On Trump RX, [00:30:28] the average price of injectables and [00:30:30] orals will start at $350 on average. [00:30:35] That's compared to roughly $500 today. [00:30:38] And that will trend down to, you guessed [00:30:40] it, the same $245 a month over the next [00:30:44] 24 months. That is one of the list [00:30:47] price. It is one half of the best price [00:30:50] in the United States today. We're [00:30:52] hoping, Mr. President, that your friend [00:30:54] who has to travel to England to afford [00:30:56] these drugs will no longer need to do so [00:30:58] and can come and do it in the United [00:30:59] States. Uh, I'll also just mention that [00:31:02] the $149 is $1 less than what you asked [00:31:06] us to achieve. [00:31:08] [laughter] [00:31:08] Just gonna make sure that's clear. So, I [00:31:12] want to highlight two other really [00:31:13] important points that make me love this [00:31:15] deal so very much. First, this isn't [00:31:17] about spending more. It's about spending [00:31:19] smarter. Uh uh the savings from the [00:31:21] diabetes drug price reductions are being [00:31:24] used in a costneutral way to fund the [00:31:27] new indications for taxpayers. That's [00:31:30] amazing. And that happens inside of that [00:31:32] same 24-month period. It's costneutral. [00:31:35] We're spending the money more wisely. [00:31:37] But second, this isn't just about lower [00:31:39] drug prices for Americans, though it [00:31:40] does do that. But together with physical [00:31:42] activity, with healthy eating and diet, [00:31:45] and where appropriate, the use of [00:31:47] breakthrough GLP1s, the real return on [00:31:50] investment is healthier Americans, lower [00:31:52] chronic disease, lower costs, we [00:31:55] estimate, by tens of billions of dollars [00:31:56] a year, and most importantly, higher [00:31:59] productivity. Today is about freeing [00:32:02] Americans from the weight, literally and [00:32:05] figuratively, that holds us back. It's [00:32:09] about unlocking the potential of every [00:32:11] citizen to live fully, to contribute [00:32:15] fully, and to find joy in their health. [00:32:18] We cannot reach our full potential as a [00:32:20] nation if we do not reach our full [00:32:22] potential as individuals. And we cannot [00:32:24] reach our full potential as individuals [00:32:26] if we are not healthy. [00:32:29] Thanks to Nova and Lily for showing up [00:32:31] so constructively over the last several [00:32:33] months to make this possible. In [00:32:35] particular, thanks to you, Mr. president [00:32:37] for again demonstrating that you fight [00:32:39] for every American, this time for [00:32:41] potential. It's now my sincere pleasure [00:32:44] to first introduce Dave Ricks from Lily [00:32:47] and then Mike Dust from Novo. [00:32:51] >> Great. Thank you, Chris. Um, it's truly [00:32:54] an honor to be here today uh for this [00:32:57] historic step forward to expand access [00:33:00] to a class of medications that can [00:33:02] fundamentally change the arc of chronic [00:33:05] disease in our country. Of course, these [00:33:07] are the inkerten or gp1 agonist that [00:33:10] we've been speaking about for nearly 150 [00:33:13] years. Uh, my company Eli Liy has been [00:33:16] investing in America. We've been [00:33:17] advancing science and creating high-v [00:33:19] value jobs. But today we Oh, you okay? [00:33:24] >> Gordon, you okay? [00:33:30] >> Yeah. [00:33:36] >> Thank you, Press. [00:33:39] Cameras, we're done.